New to Podcasts?
CNS Summit Podcast

CNS Summit Podcast

Collaborating for Novel Solutions, Shaping the Future

Latest From Series

S1: E4: Myrtle Potter of Roivant Sciences on the near future of drug development innovation

Myrtle Potter is one of America’s foremost healthcare leaders and innovators. She is Vant Operating Chair at Roivant Sciences, a global biopharmaceutical company that currently has thirty investigational drugs in eleven therapeutic areas being tested in over fifty clinical trials across the Roivant family of companies. She is also founder of Myrtle Potter & Company, LLC, a healthcare and life science advisory firm that has operated since 2005. Myrtle was president and chief operating officer of Genentech, Inc. where, from 2000 to 2005, she led the company through one of the most successful periods in its history. Genentech achieved record sales and earnings growth during each of the five years she led the company and sales grew more than five-fold to over $5 billion over the same period. Under her leadership the company launched seven breakthrough products including Avastin™, the blockbuster cancer treatment. During her tenure she served on the Executive Committee of the Company and co-chaired the Product Portfolio Committee which made all investment and “go/no go” decisions for Genentech’s drug pipeline. Myrtle is also an independent director of Rite Aid Corporation, Liberty Mutual Holding Company, Proteus Digital Health, Insmed and Axsome. She also serves on the University of Chicago Board of Trustees. Formerly she served on the boards of Amazon, FoxHollow Technologies, eV3, Medco Health Solutions and Express Scripts Myrtle was named to FORTUNE Magazine’s list of Most Powerful Women in Business on three separate occasions. Her business and leadership has been recognized by BusinessWeek, The Wall Street Journal, FORTUNE Magazine, TIME Magazine, Forbes, Black Enterprise Magazine, Savoy and Harvard Business Review. Myrtle earned a B.A. from The University of Chicago. Learn more about the CNS Summit and follow us on Twitter (@cnssummit). Listen to this episode on Health Podcast Network.
October 31, 2019

S1: E3: Eric Perkaslis on research, informatics, technology

Eric is currently Chief Science Officer at Datavant and Visiting Scientist at the Department of Biomedical Informatics at Harvard Medical School. Most recently, Eric was Senior Vice President Data Sciences at Takeda R&D. Previously, Eric was the Executive Director of the Center for Biomedical Informatics and the Countway Library of Medicine at Harvard Medical School. Eric served as the CIO and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. Eric has also served as Senior Bioinformatics Advisor at Precision for Medicine, as the Chair of the ASCO CancerLinQ technology advisory and on the Editorial Board of the DIA flagship journal, Journal of Regulatory Science and Innnovation Prior to FDA, Eric was Senior Vice President of R&D IT at J&J Pharmaceuticals R&D. Eric also held the posts of Vice President R&D Informatics, Vice President and CIO, Director of Research IT, Assistant Director and Director of Drug Discovery Research at J&J. Eric has a PhD in chemical and biochemical engineering from Drexel University. Learn more about the CNS Summit and follow us on Twitter (@cnssummit). Listen to this episode on Health Podcast Network.
October 31, 2019

S1: E2: A conversation with Deborah Dunsire, CEO and President of Lundbeck

Deborah Dunsire is the CEO and President of Lundbeck. Prior to that, she was the CEO and President of FORUM Pharmaceuticals and the CEO and President at Millennium Pharmaceuticals. She has more than 25 years of scientific, clinical, operational and commercial experience, and proven leadership in the biological and pharmaceutical industry. Dr. Dunsire holds a Doctor of Medicine from the University of Witwatersand, Johannesburg, South Africa. Learn more about the CNS Summit and follow us on Twitter (@cnssummit). Listen to this episode on Health Podcast Network.
October 31, 2019

S1: E1: Insights from Vivek Ramaswamy, founder and CEO, Roivant Sciences

Vivek Ramaswamy is the founder and CEO of Roivant Sciences, the parent of a growing family of companies focused on diverse areas including women’s health, rare diseases, neurology, cardiometabolic diseases, urology, dermatology, RNA therapeutics, and healthcare data.  Learn more about the CNS Summit and follow us on Twitter (@cnssummit). Listen to this episode on Health Podcast Network.
October 30, 2019

Welcome! Introducing the CNS Summit Podcast

Hi everyone this is Amir Kalali. I am a physician researcher focused on the intersection of life sciences and technology. Welcome to the CNS Summit podcasts, a new series of podcasts created in partnership with the Health Podcast Network and Mission Based Media.  This new series is designed to share the insights and information shared by leaders at the CNS Summit. CNS Summit was founded by life science leaders in 2009 and has developed into a global community of leaders who are passionate about shaping the future, with a focus on collaboration, innovation, and technology.  Our mission is to have a positive impact on the success of clinical development programs. We believe this mission is our ethical duty to the patients we serve by developing new treatments. If this mission resonates with you, and you would like to be surrounded by creative, passionate, and future-focused colleagues, join us. In this series, we’ll bring you a selection keynotes and conversations featuring some of the most interesting speakers in the industry. You can learn more about CNS Summit by visiting cnssummit.org.   You can also find all the episodes of the CNS Summit podcast there on our website, as well as the Health Podcast Network. From there, you can stream or download the podcasts that matter most to you. Once again, welcome to the CNS Summit podcast, and I look forward to the opportunity of meeting many of you soon.
October 22, 2019

CNS Summit Podcast

CNS Summit is a platform for change and a community passionate about shaping the future, with a focus on collaboration, innovation, and technology. Our mission is to have a positive impact on the success of clinical development programs. We believe this mission is our ethical duty to the patients we serve by developing new treatments. If this mission resonates with you, and you would like to be surrounded by creative, passionate, and future-focused colleagues.
View All Episodes

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover Welcome to the Health Podcast Network!
00:00
00:00
volume-low